Real-time monitoring efficiency and toxicity of chemotherapy in patients with advanced lung cancer

Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer

(2014) Shicheng Guo et al.   Clinical Epigenetics

Can plasma DNA monitoring be employed in personalized chemotherapy for patients with advanced lung cancer?

(2012) Shiyang Pan et al.   BIOMEDICINE & PHARMACOTHERAPY

Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib

(2012) E. A. Punnoose et al.   CLINICAL CANCER RESEARCH

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

(2012) Julian R. Molina et al.   MAYO CLINIC PROCEEDINGS

Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer

(2011) Youwei Zhang et al.   CANCER LETTERS

An Epigenetic Marker Panel for Detection of Lung Cancer Using Cell-Free Serum DNA

(2011) S. Begum et al.   CLINICAL CANCER RESEARCH

The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer

(2011) Kenneth J. O’Byrne et al.   Cancers

Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis

(2010) Thomas Liggett et al.   CANCER

Plasma cell-free DNA in ovarian cancer

(2010) Aparna A. Kamat et al.   CANCER

Circulating Nucleic Acids as a Potential Source for Cancer Biomarkers

(2010) V. Vlassov et al.   CURRENT MOLECULAR MEDICINE

Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer

(2010) S. Kumar et al.   EUROPEAN RESPIRATORY JOURNAL

Early detection and screening of lung cancer

(2010) Celine Mascaux et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Cancer epigenomics: Implications of DNA methylation in personalized cancer therapy

(2009) Minoru Toyota et al.   CANCER SCIENCE

DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type

(2009) Stephen E. Hawes et al.   LUNG CANCER

Molecular Selection of Patients for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer With Epidermal Growth Factor Inhibitors: Not Quite Ready for Prime Time

(2008) Frances A. Shepherd   JOURNAL OF CLINICAL ONCOLOGY

Individual Fluorouracil Dose Adjustment Based on Pharmacokinetic Follow-Up Compared With Conventional Dosage: Results of a Multicenter Randomized Trial of Patients With Metastatic Colorectal Cancer

(2008) Erick Gamelin et al.   JOURNAL OF CLINICAL ONCOLOGY

First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations

(2008) Lecia V. Sequist et al.   JOURNAL OF CLINICAL ONCOLOGY

Proteomic Contributions to Personalized Cancer Care

(2008) John M. Koomen et al.   MOLECULAR & CELLULAR PROTEOMICS

DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer

(2008) Malcolm V. Brock et al.   NEW ENGLAND JOURNAL OF MEDICINE